{"id":30886,"date":"2014-09-11T07:05:50","date_gmt":"2014-09-11T11:05:50","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=30886"},"modified":"2014-09-11T07:05:50","modified_gmt":"2014-09-11T11:05:50","slug":"nps-pharmaceuticals-inc-nasdaqnpsps-biologics-license-application-for-natpara-to-be-taken-up-by-food-and-drug-administration-committee","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/nps-pharmaceuticals-inc-nasdaqnpsps-biologics-license-application-for-natpara-to-be-taken-up-by-food-and-drug-administration-committee-30886","title":{"rendered":"NPS Pharmaceuticals, Inc. (NASDAQ:NPSP)\u2019s Biologics License Application for Natpara To Be Taken Up By Food And Drug Administration Committee"},"content":{"rendered":"<p style=\"text-align: justify;\">Boston, MA 09\/11\/2014 (wallstreetpr) \u2013 Biopharmaceutical company focused on delivering therapies, <strong>NPS Pharmaceuticals, Inc. (NASDAQ:NPSP)<\/strong> disclosed that the Food and Drug Administration in the U.S. would decide its Biologics License Application or BLA for Natpara on September 12.<\/p>\n<p style=\"text-align: justify;\"><strong>Committee To Decide<\/strong><\/p>\n<p style=\"text-align: justify;\">The company said that the regulator has posted briefing materials for the Endocrinologic and Metabolic Drugs Advisory Committee or EMDAC meeting scheduled for Friday, according to the <a href=\"http:\/\/finance.yahoo.com\/news\/fda-posts-briefing-materials-advisory-120400073.html\" target=\"_blank\">company\u2019s statement<\/a>. The committee would review its BLA for Natpara and decide whether it can be approved or not.<\/p>\n<p style=\"text-align: justify;\">NPS Pharmaceuticals, Inc. (NASDAQ:NPSP)\u00a0said that MDAC would review the available data and evaluate the effectiveness and safety of investigational and marketed human drug products to be used for endocrine and metabolic disorders treatment. The committee would then recommend its opinion or actions to the FDA. The medical regulator would review the recommendations of the committee and decide the outcome of the company\u2019s BLA for Natpara.\u00a0NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) indicated that the Prescription Drug User Fee Act date for completing the review of Natpara BLA was fixed for October 24.<\/p>\n<p style=\"text-align: justify;\">NPS Pharmaceuticals, Inc. (NASDAQ:NPSP)\u00a0said that it has developed Natpara as a bioengineering replacement treatment for endogenous parathyroid hormone or PTH for treating Hypoparathyroidism, which was termed as a rare endocrine disorder differentiated by deficiency in the PTH levels.<\/p>\n<p style=\"text-align: justify;\"><strong>Preliminary Review Results<\/strong><\/p>\n<p style=\"text-align: justify;\">The preliminary review done by the FDA was positive for NPS Pharmaceuticals, Inc. (NASDAQ:NPSP). Its drug candidate, Natpara, has reduced vitamin D supplements and Calcium in clinical trials, <a href=\"http:\/\/finance.yahoo.com\/news\/fda-staff-nps-drug-effective-124709397.html\" target=\"_blank\">Reuters<\/a> reported. However, data from one trial was not taken into consideration due to violations in manufacturing, the report said quoting FDA\u2019s preliminary review.<\/p>\n<p style=\"text-align: justify;\">The reviewers said that there was a similarity of some serious adverse events between the placebo group and the treatment group. The FDA has posted its review report on its website, just two days ahead of its MDAC meeting. The report said that Natpara drug was effective and that there was no significant safety imbalance.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Boston, MA 09\/11\/2014 (wallstreetpr) \u2013 Biopharmaceutical company focused on delivering therapies, NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) disclosed that the Food and Drug Administration in the U.S. [&hellip;]<\/p>\n","protected":false},"author":12,"featured_media":24319,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[264,263],"tags":[4302,4301],"stock_ticker":[],"class_list":["post-30886","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","category-technology","tag-nasdaqnpsp","tag-nps-pharmaceuticals-inc-nasdaqnpsp","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>NPS Pharmaceuticals, Inc. (NASDAQ:NPSP)\u2019s Biologics License Application for Natpara To Be Taken Up By Food And Drug Administration Committee - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/nps-pharmaceuticals-inc-nasdaqnpsps-biologics-license-application-for-natpara-to-be-taken-up-by-food-and-drug-administration-committee-30886\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"NPS Pharmaceuticals, Inc. (NASDAQ:NPSP)\u2019s Biologics License Application for Natpara To Be Taken Up By Food And Drug Administration Committee - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Boston, MA 09\/11\/2014 (wallstreetpr) \u2013 Biopharmaceutical company focused on delivering therapies, NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) disclosed that the Food and Drug Administration in the U.S. [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/nps-pharmaceuticals-inc-nasdaqnpsps-biologics-license-application-for-natpara-to-be-taken-up-by-food-and-drug-administration-committee-30886\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2014-09-11T11:05:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/06\/NPS-Pharmaceuticals.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"808\" \/>\n\t<meta property=\"og:image:height\" content=\"808\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Steve Hackney\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Steve Hackney\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/nps-pharmaceuticals-inc-nasdaqnpsps-biologics-license-application-for-natpara-to-be-taken-up-by-food-and-drug-administration-committee-30886#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/nps-pharmaceuticals-inc-nasdaqnpsps-biologics-license-application-for-natpara-to-be-taken-up-by-food-and-drug-administration-committee-30886\"},\"author\":{\"name\":\"Steve Hackney\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/3ce02e36ec0c7fc865d70f316a025867\"},\"headline\":\"NPS Pharmaceuticals, Inc. (NASDAQ:NPSP)\u2019s Biologics License Application for Natpara To Be Taken Up By Food And Drug Administration Committee\",\"datePublished\":\"2014-09-11T11:05:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/nps-pharmaceuticals-inc-nasdaqnpsps-biologics-license-application-for-natpara-to-be-taken-up-by-food-and-drug-administration-committee-30886\"},\"wordCount\":353,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/nps-pharmaceuticals-inc-nasdaqnpsps-biologics-license-application-for-natpara-to-be-taken-up-by-food-and-drug-administration-committee-30886#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/06\/NPS-Pharmaceuticals.jpg\",\"keywords\":[\"NASDAQ:NPSP\",\"NPS Pharmaceuticals Inc. (NASDAQ:NPSP)\"],\"articleSection\":[\"Health\",\"Technology\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/nps-pharmaceuticals-inc-nasdaqnpsps-biologics-license-application-for-natpara-to-be-taken-up-by-food-and-drug-administration-committee-30886#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/nps-pharmaceuticals-inc-nasdaqnpsps-biologics-license-application-for-natpara-to-be-taken-up-by-food-and-drug-administration-committee-30886\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/nps-pharmaceuticals-inc-nasdaqnpsps-biologics-license-application-for-natpara-to-be-taken-up-by-food-and-drug-administration-committee-30886\",\"name\":\"NPS Pharmaceuticals, Inc. (NASDAQ:NPSP)\u2019s Biologics License Application for Natpara To Be Taken Up By Food And Drug Administration Committee - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/nps-pharmaceuticals-inc-nasdaqnpsps-biologics-license-application-for-natpara-to-be-taken-up-by-food-and-drug-administration-committee-30886#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/nps-pharmaceuticals-inc-nasdaqnpsps-biologics-license-application-for-natpara-to-be-taken-up-by-food-and-drug-administration-committee-30886#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/06\/NPS-Pharmaceuticals.jpg\",\"datePublished\":\"2014-09-11T11:05:50+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/nps-pharmaceuticals-inc-nasdaqnpsps-biologics-license-application-for-natpara-to-be-taken-up-by-food-and-drug-administration-committee-30886#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/nps-pharmaceuticals-inc-nasdaqnpsps-biologics-license-application-for-natpara-to-be-taken-up-by-food-and-drug-administration-committee-30886\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/nps-pharmaceuticals-inc-nasdaqnpsps-biologics-license-application-for-natpara-to-be-taken-up-by-food-and-drug-administration-committee-30886#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/06\/NPS-Pharmaceuticals.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/06\/NPS-Pharmaceuticals.jpg\",\"width\":808,\"height\":808},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/nps-pharmaceuticals-inc-nasdaqnpsps-biologics-license-application-for-natpara-to-be-taken-up-by-food-and-drug-administration-committee-30886#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"NPS Pharmaceuticals, Inc. (NASDAQ:NPSP)\u2019s Biologics License Application for Natpara To Be Taken Up By Food And Drug Administration Committee\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/3ce02e36ec0c7fc865d70f316a025867\",\"name\":\"Steve Hackney\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/d6e4a33d4904dade1e565fa07bb4bc099f7c12bc3da9ba57311e75086b1e91e8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/d6e4a33d4904dade1e565fa07bb4bc099f7c12bc3da9ba57311e75086b1e91e8?s=96&d=mm&r=g\",\"caption\":\"Steve Hackney\"},\"description\":\"Steve Hackney is a corporate finance professional with over 14 years of experience in cash management and investing. He earned a Bachelor of Science in Finance from Florida State University and holds a Certified Treasury Professional certification. Steve lives in Orlando, Florida with his family.\",\"sameAs\":[\"https:\/\/cablemanpro.com\/wallstreetpr\"],\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/steve-hackney\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"NPS Pharmaceuticals, Inc. (NASDAQ:NPSP)\u2019s Biologics License Application for Natpara To Be Taken Up By Food And Drug Administration Committee - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/nps-pharmaceuticals-inc-nasdaqnpsps-biologics-license-application-for-natpara-to-be-taken-up-by-food-and-drug-administration-committee-30886","og_locale":"en_US","og_type":"article","og_title":"NPS Pharmaceuticals, Inc. (NASDAQ:NPSP)\u2019s Biologics License Application for Natpara To Be Taken Up By Food And Drug Administration Committee - Wall Street PR","og_description":"Boston, MA 09\/11\/2014 (wallstreetpr) \u2013 Biopharmaceutical company focused on delivering therapies, NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) disclosed that the Food and Drug Administration in the U.S. [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/nps-pharmaceuticals-inc-nasdaqnpsps-biologics-license-application-for-natpara-to-be-taken-up-by-food-and-drug-administration-committee-30886","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2014-09-11T11:05:50+00:00","og_image":[{"width":808,"height":808,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/06\/NPS-Pharmaceuticals.jpg","type":"image\/jpeg"}],"author":"Steve Hackney","twitter_misc":{"Written by":"Steve Hackney","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/nps-pharmaceuticals-inc-nasdaqnpsps-biologics-license-application-for-natpara-to-be-taken-up-by-food-and-drug-administration-committee-30886#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/nps-pharmaceuticals-inc-nasdaqnpsps-biologics-license-application-for-natpara-to-be-taken-up-by-food-and-drug-administration-committee-30886"},"author":{"name":"Steve Hackney","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/3ce02e36ec0c7fc865d70f316a025867"},"headline":"NPS Pharmaceuticals, Inc. (NASDAQ:NPSP)\u2019s Biologics License Application for Natpara To Be Taken Up By Food And Drug Administration Committee","datePublished":"2014-09-11T11:05:50+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/nps-pharmaceuticals-inc-nasdaqnpsps-biologics-license-application-for-natpara-to-be-taken-up-by-food-and-drug-administration-committee-30886"},"wordCount":353,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/nps-pharmaceuticals-inc-nasdaqnpsps-biologics-license-application-for-natpara-to-be-taken-up-by-food-and-drug-administration-committee-30886#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/06\/NPS-Pharmaceuticals.jpg","keywords":["NASDAQ:NPSP","NPS Pharmaceuticals Inc. (NASDAQ:NPSP)"],"articleSection":["Health","Technology"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/nps-pharmaceuticals-inc-nasdaqnpsps-biologics-license-application-for-natpara-to-be-taken-up-by-food-and-drug-administration-committee-30886#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/nps-pharmaceuticals-inc-nasdaqnpsps-biologics-license-application-for-natpara-to-be-taken-up-by-food-and-drug-administration-committee-30886","url":"https:\/\/cablemanpro.com\/wallstreetpr\/nps-pharmaceuticals-inc-nasdaqnpsps-biologics-license-application-for-natpara-to-be-taken-up-by-food-and-drug-administration-committee-30886","name":"NPS Pharmaceuticals, Inc. (NASDAQ:NPSP)\u2019s Biologics License Application for Natpara To Be Taken Up By Food And Drug Administration Committee - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/nps-pharmaceuticals-inc-nasdaqnpsps-biologics-license-application-for-natpara-to-be-taken-up-by-food-and-drug-administration-committee-30886#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/nps-pharmaceuticals-inc-nasdaqnpsps-biologics-license-application-for-natpara-to-be-taken-up-by-food-and-drug-administration-committee-30886#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/06\/NPS-Pharmaceuticals.jpg","datePublished":"2014-09-11T11:05:50+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/nps-pharmaceuticals-inc-nasdaqnpsps-biologics-license-application-for-natpara-to-be-taken-up-by-food-and-drug-administration-committee-30886#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/nps-pharmaceuticals-inc-nasdaqnpsps-biologics-license-application-for-natpara-to-be-taken-up-by-food-and-drug-administration-committee-30886"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/nps-pharmaceuticals-inc-nasdaqnpsps-biologics-license-application-for-natpara-to-be-taken-up-by-food-and-drug-administration-committee-30886#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/06\/NPS-Pharmaceuticals.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/06\/NPS-Pharmaceuticals.jpg","width":808,"height":808},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/nps-pharmaceuticals-inc-nasdaqnpsps-biologics-license-application-for-natpara-to-be-taken-up-by-food-and-drug-administration-committee-30886#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"NPS Pharmaceuticals, Inc. (NASDAQ:NPSP)\u2019s Biologics License Application for Natpara To Be Taken Up By Food And Drug Administration Committee"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/3ce02e36ec0c7fc865d70f316a025867","name":"Steve Hackney","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/d6e4a33d4904dade1e565fa07bb4bc099f7c12bc3da9ba57311e75086b1e91e8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d6e4a33d4904dade1e565fa07bb4bc099f7c12bc3da9ba57311e75086b1e91e8?s=96&d=mm&r=g","caption":"Steve Hackney"},"description":"Steve Hackney is a corporate finance professional with over 14 years of experience in cash management and investing. He earned a Bachelor of Science in Finance from Florida State University and holds a Certified Treasury Professional certification. Steve lives in Orlando, Florida with his family.","sameAs":["https:\/\/cablemanpro.com\/wallstreetpr"],"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/steve-hackney"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/30886","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=30886"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/30886\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/24319"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=30886"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=30886"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=30886"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=30886"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}